欢迎来到天天文库
浏览记录
ID:54983798
大小:227.11 KB
页数:3页
时间:2020-05-07
《冠心病合并2型糖尿病患者profilin-1、晚期糖基化终产物受体水平及临床意义-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、2O14.30临床心血管病杂志(8):685—687JournalofClinicalCardiology(China)·685·冠心病合并2型糖尿病患者profilin一1、晚期糖基化终产物受体水平及临床意义*杨达峰马丽平杨天伦谢秀梅陈美芳[摘要]目的:检测冠心病(CHD)及冠心病合并糖尿病(DM)患者血浆中profilin-1、晚期糖基化终产物受体(RAGE)的水平,并进一步探讨其临床意义。方法:入选89例研究对象,其中对照组27例,CHD组31例,CHD合并DM组31例。空腹采集外周静脉血,采用ELISA法检测血浆profilin一1与RAGE水平;收集一般临床资料及常规
2、生化指标,根据Gensini积分系统计算冠状动脉(冠脉)狭窄程度。结果:①CHD组和CHD合并DM组患者血浆profilin-1及RAGE水平以及Gensini积分明显高于对照组(P<0.05),CHD合并DM组更为明显(P<0.05);②血浆profilin-1水平与RAGE水平呈正相关(R一0.7161,P<0.05),血浆profilin-1、RAGE水平与Gensini积分呈正相关(R一0.7494、0.8424,P<0.05)。结论:CHD合并2型DM患者血浆profilin-1与RAGE水平明显高于单纯CHD患者,且profilin-1与RAGE水平与Gensini
3、积分呈正相关,提示血浆profilin一1与RAGE水平可在一定程度上反映冠脉狭窄程度。[关键词]冠心病;糖尿病;profilin一1;晚期糖基化产物受体;Gensini积分doi:10.13201/j.issn.1001~1439.2014.08.010[中图分类号]R541.4[文献标志码]AThelevelsandclinicalsignificanceofprofilin一1,RAGEinpatientswithCHDcombinedwithtype2DMYANGDafengMALipingYANGTianlunXIEXiumeiCHENMeig(Departmento
4、fCardiovascularMedicine,DepartmentofGeriatricMedicine,XiangyaHospi~tal,CentralSouthUniversity,Changsha,410008,China)Correspondingauthor:CHENMeifang,E—mail:meifangl21@sohu.cornAbstractObjective:Toinvestigatethelevelsandpossibleclinicalsignificanceofprofilin-1,receptorforad—vancedglycationendp
5、roducts(RAGE)inthepatientswithcoronaryheartdisease(CHD)andCHDcompaniedwithdiabetesmellitus(DM).Method:Atotalof89patientswereenrolledinthisstudyincluding27individualsincontrolgroup,31individualsinCHDgroupand81patientsinCHD+DMgroup.Plasmalevelsofprofilin-1andRAGEweredeterminedbyELISA.andthedeg
6、reeofcoronarystenosiswascalculatedaccordingtotheGensiniscoringsystem.Result:①Plasmalevelsofprofilin-1,RAGEandGensiniscoresweresignificantlyhigherinCHDorCHD+DMgroupthanthoseincontrolcontrol(P7、EorGensiniscores(R。一0.7161,0.7494,bothP
7、EorGensiniscores(R。一0.7161,0.7494,bothP
此文档下载收益归作者所有